Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129,337,627
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
23,270,576
-
Shares change
-
-10,353,292
-
Total reported value, excl. options
-
$25,392,308
-
Value change
-
-$11,443,285
-
Put/Call ratio
-
70%
-
Number of buys
-
19
-
Number of sells
-
47
-
Price
-
$1.09
Institutional Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q2 2022
As of 30 Jun 2022 ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) had 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,270,576 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., D. E. Shaw & Co., Inc., Laurion Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, SABBY MANAGEMENT, LLC, Ergoteles LLC, and STATE STREET CORP.
This table shows 100 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.